Early muscle system cancer is outlined as growth restricted to the mucous membrane or connective tissue, and while not bodily fluid unfold or distant metastasis. Intraepithelial pathological process, as well as inferior and top-quality intraepithelial pathological process (HGIN), is outlined because the metastatic tumor modification of muscle system cancer. Recent advances in examination technology have accrued detection rates of early muscle system cancer. In thirty first of patients the muscle system cancer is detected early in place. in conjunction with examination detection, additional and additional early muscle system lesions are additionally treated by examination choices. Compared with standard esophagectomy, examination therapies for intraepithelial pathological process and early muscle system cancer ar viable alternatives with considerably lower morbidities. examination diagnosing and treatment for early muscle system cancer has diagrammatic the trend of future. Thus, this review summarizes recent progress on examination diagnosing and treatment choices for early muscle system cancer. Recently, the authors from Asia Pacific countries additionally incontestible that NBI is helpful for detection and characterization of superficial muscle system epithelial cell cancer (SCC), and will replace chromoendoscopy in routine examination as a result of it's straightforward to use and adds abundant data to standard white light-weight.